Loading patent…
AssigneesUniversite De La Rochelle, Universite Clermont Auvergne
InventorsThierry Maugard, Stephanie Bordenave-Juchereau, Jean-Marie Piot, Yesmine Ben-Henda, Pascal Sirvent, Sebastien Peltier
Estimating the term…
A composition including at least one XAP peptide, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase. Also, the use of a hydrolysate of at least one protein, the protein including or constituted by at least 0.05% to <5% or of at least 5% of XAP units, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase.
A method for reducing glycemia by inhibiting alpha-glucosidase, said method comprising administering to a subject in need thereof a composition comprising at least one XAP peptide, in which X represents the empty set or a valine, wherein the XAP peptide is administered before or during a meal.
Dependencies are inferred from the claim text.